Provided by Tiger Fintech (Singapore) Pte. Ltd.

Madrigal Pharmaceuticals

345.73
+3.441.00%
Post-market: 351.005.27+1.52%19:59 EDT
Volume:355.25K
Turnover:122.48M
Market Cap:7.71B
PE:-26.98
High:348.34
Open:340.98
Low:339.31
Close:342.29
52wk High:377.46
52wk Low:200.63
Shares:22.29M
Float Shares:11.00M
Volume Ratio:0.68
T/O Rate:3.23%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-12.8155
EPS(LYR):-21.9007
ROE:-36.30%
ROA:-18.31%
PB:11.07
PE(LYR):-15.79

Loading ...

Madrigal Pharmaceuticals Q1 EPS $(3.32) Beats $(3.61) Estimate, Sales $137.25M Beat $113.76M Estimate

Benzinga
·
May 01

BRIEF-Madrigal Pharmaceuticals Q1 EPS USD -3.32

Reuters
·
May 01

Madrigal Pharmaceuticals announces six presentations at EASL Congress

TIPRANKS
·
Apr 29

Madrigal to Present Late-Breaking Resmetirom Data in Patients with Compensated MASH Cirrhosis at the EASL Congress

GlobeNewswire
·
Apr 29

Exploring High Growth Tech Stocks in the US Market

Simply Wall St.
·
Apr 29

Madrigal Pharmaceuticals Price Target Maintained With a $443.00/Share by JMP Securities

Dow Jones
·
Apr 24

Madrigal Pharmaceuticals to Release First-Quarter 2025 Financial Results and Host Webcast on May 1, 2025

GlobeNewswire
·
Apr 18

Madrigal Pharmaceuticals Announces Leadership Transition

TIPRANKS
·
Apr 18

BRIEF-Madrigal Pharmaceuticals Announces Company Founder Rebecca Taub, M.D. To Become Senior Scientific And Medical Advisor David Soergel, M.D., Appointed Chief Medical Officer

Reuters
·
Apr 16

Is Madrigal Pharmaceuticals (MDGL) The Most Expensive Stock Insiders Are Dumping In March?

Insider Monkey
·
Mar 29

Exploring 3 High Growth Tech Stocks in the US Market

Simply Wall St.
·
Mar 29

Analysts Expect Breakeven For Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Before Long

Simply Wall St.
·
Mar 26

Madrigal Pharmaceuticals (MDGL): Among the Best Biotech Stocks to Buy According to Billionaires

Insider Monkey
·
Mar 18

Madrigal Pharmaceuticals appoints Fouse to its board of directors

TIPRANKS
·
Mar 11

Press Release: Madrigal Appoints Jacqualyn A. Fouse, Ph.D. to Its Board of Directors

Dow Jones
·
Mar 11

Madrigal Pharmaceuticals Exec Cashes Out in Multi-Million Dollar Stock Sale!

TIPRANKS
·
Mar 08

TD Cowen Sticks to Their Buy Rating for Madrigal Pharmaceuticals (MDGL)

TIPRANKS
·
Mar 06

B. Riley Upgrades Madrigal Pharmaceuticals to Buy From Neutral, Raises Price Target to $422 From $236

MT Newswires Live
·
Feb 28

Madrigal Pharmaceuticals Is Maintained at Buy by Citigroup

Dow Jones
·
Feb 28

Madrigal Pharmaceuticals Shares Still Undervalued Amid Long-Term Growth Potential, UBS Says

MT Newswires Live
·
Feb 28